137 related articles for article (PubMed ID: 29997233)
1. Lumbar drains can affect CSF biomarker levels.
Craven CL; Chapman MD; D'Antona L; Thompson SD; Lakdawala N; Zetterberg H; Watkins LD; Toma AK
J Clin Pathol; 2019 Jan; 72(1):91-92. PubMed ID: 29997233
[No Abstract] [Full Text] [Related]
2. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40).
Vanderstichele H; Demeyer L; Janelidze S; Coart E; Stoops E; Mauroo K; Herbst V; François C; Hansson O
Alzheimers Res Ther; 2017 Jun; 9(1):40. PubMed ID: 28587660
[TBL] [Abstract][Full Text] [Related]
3. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus.
Graff-Radford NR
Neurology; 2014 Oct; 83(17):1573-5. PubMed ID: 25332445
[TBL] [Abstract][Full Text] [Related]
5. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus.
Brandner S; Thaler C; Lelental N; Buchfelder M; Kleindienst A; Maler JM; Kornhuber J; Lewczuk P
J Alzheimers Dis; 2014; 41(4):1057-62. PubMed ID: 24748118
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.
Gloeckner SF; Meyne F; Wagner F; Heinemann U; Krasnianski A; Meissner B; Zerr I
J Alzheimers Dis; 2008 May; 14(1):17-25. PubMed ID: 18525124
[TBL] [Abstract][Full Text] [Related]
7. Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus.
Djukic M; Spreer A; Lange P; Bunkowski S; Wiltfang J; Nau R
Fluids Barriers CNS; 2016 Aug; 13(1):15. PubMed ID: 27581842
[TBL] [Abstract][Full Text] [Related]
8. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
Miyajima M; Nakajima M; Ogino I; Miyata H; Motoi Y; Arai H
Eur J Neurol; 2013 Feb; 20(2):236-42. PubMed ID: 22672777
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease.
Kapaki EN; Paraskevas GP; Tzerakis NG; Sfagos C; Seretis A; Kararizou E; Vassilopoulos D
Eur J Neurol; 2007 Feb; 14(2):168-73. PubMed ID: 17250725
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.
Buchhave P; Minthon L; Zetterberg H; Wallin AK; Blennow K; Hansson O
Arch Gen Psychiatry; 2012 Jan; 69(1):98-106. PubMed ID: 22213792
[TBL] [Abstract][Full Text] [Related]
11. Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.
Pijnenburg YA; Schoonenboom NS; Scheltens P
Neurology; 2003 Jan; 60(2):353-4; author reply 353-4. PubMed ID: 12552068
[No Abstract] [Full Text] [Related]
12. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.
Santangelo R; Cecchetti G; Bernasconi MP; Cardamone R; Barbieri A; Pinto P; Passerini G; Scomazzoni F; Comi G; Magnani G
J Alzheimers Dis; 2017; 60(1):183-200. PubMed ID: 28826180
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
Kang K; Ko PW; Jin M; Suk K; Lee HW
J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort.
Schoonenboom NS; Reesink FE; Verwey NA; Kester MI; Teunissen CE; van de Ven PM; Pijnenburg YA; Blankenstein MA; Rozemuller AJ; Scheltens P; van der Flier WM
Neurology; 2012 Jan; 78(1):47-54. PubMed ID: 22170879
[TBL] [Abstract][Full Text] [Related]
17. Clinical Consensus Guidelines on the Application of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: Recommendations of the Irish Network for Biomarkers in Neurodegeneration.
Miller AM; Begley E; Coen R; Doyle M; Dunne J; Hutchinson S; Kennelly SP; Kenny RA; Killeen RP; Lynch A; O'Dwyer S; O'Neill C; O'Sullvan SS; Rowan MJ; Sheehy N; McGuigan C; Lawlor BA
Ir Med J; 2016 Dec; 109(10):483. PubMed ID: 28644588
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis.
Perret-Liaudet A; Pelpel M; Tholance Y; Dumont B; Vanderstichele H; Zorzi W; ElMoualij B; Schraen S; Moreaud O; Gabelle A; Thouvenot E; Thomas-Anterion C; Touchon J; Krolak-Salmon P; Kovacs GG; Coudreuse A; Quadrio I; Lehmann S
Clin Chem; 2012 Apr; 58(4):787-9. PubMed ID: 22322825
[No Abstract] [Full Text] [Related]
20. A cerebrospinal fluid biosignature for the diagnosis of Alzheimer's disease.
Barichello T; Giridharan VV; Dal-Pizzol F
Braz J Psychiatry; 2019; 41(6):467-468. PubMed ID: 31826090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
